PATENT CLAIM ANALYSIS

Application Number: 15760263
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "201100"]

Abstract:
The present invention discloses a process for manufacturing a formulation comprising a drug substance, said drug substance comprising a recombinant  Listeria  comprising a human papilloma virus (HPV) antigen fused to a Listeriolysin O (LLO) protein fragment. The invention further discloses methods of using treating, protecting against, and inducing an immune response against cervical cancer comprising administration of the recombinant  Listeria  strain. The present invention also provides methods for inducing an anti-E7 CTL response in a human subject and treating HPV-mediated diseases, disorders, and symptoms, comprising administration of the recombinant  Listeria  strain.

Claim (Index 14):
The process of  claim 13 , wherein said product bags are 5\u00d710 L in volume and said transferring is carried out in 1-5 kg aliquots.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 90.0
- Lexical Diversity: 1.7931
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11715497', '13314583', '15306289', '11373528', '14883557']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8081569805748282
- 35 USC 102 Novelty (BERT): 0.5512759157006141
- Combined Prediction Score: 0.7824688740874068
- Mean Citation Score: 486.261764
- Max Citation Score: 538.08765
- Similarity Product: 269.69181825946583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test